Mingren Pharmaceutical Inc. (referred to as Mingren Medicine) was founded in 2018. Mingren Medicine adheres to the philosophy of “building together, sharing, and developing together”, “seeking sincerity, seeking truth, and seeking truth”. In the past work experience, it has served well-known pharmaceutical companies in dozens of domestic and foreign industries and achieved good results. Word of mouth and reputation.

In recent years, the China Food and Drug Administration (CFDA) has successively promulgated and implemented a series of policies such as generic drug conformity evaluation, and joined the ICH organization in 2017. Its purpose is to continuously improve the technical level of production and manufacturing of Chinese pharmaceutical products and the overall quality level of pharmaceuticals. China's pharmaceutical industry has always maintained openness and exchanges. The overall level of medicine has made great progress since the reform and opening up, but there are still some stage problems compared with the level of foreign counterparts. Further strengthening the study and exchange with foreign pharmaceutical industry is one of the effective means to effectively improve China's own medical level.